文献速递头颈部肿瘤放疗

早期声门型喉癌放疗后喉功能障碍风险的系统综述与荟萃分析

Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: A systematic review and meta-analysis.
PubMed 文献 · Radiother Oncol · 2025-10-23

该系统综述与荟萃分析纳入49项研究共7033例早期声门型喉癌(cTis-cT2)接受根治性放疗的患者,评估喉功能障碍(无局部复发情况下需气管造口或喉切除术)的发生率,汇总发生率为0.3%,使用中度至(超)大分割放疗的研究中风险仍低于1%。

要点

  • 早期声门型喉癌根治性放疗后喉功能障碍汇总发生率仅0.3%。
  • 中度至(超)大分割放疗研究中喉功能障碍风险仍低于1%。
  • 结果支持当代放疗方法在该人群中保留喉功能的安全性。

核心结论

  • 早期声门型喉癌放疗后喉功能障碍总体发生率低,支持当代放疗保留喉功能的安全性。

研究设计与样本

  • 遵循PRISMA指南的系统综述与荟萃分析,文献检索截至2025年9月。
  • 纳入49项研究共7033例cTis-cT2期接受根治性放疗的声门型喉癌患者。

主要发现

  • 全部纳入研究的汇总分析显示喉功能障碍总体发生率为0.3%。
  • 使用中度至(超)大分割放疗的研究中喉功能障碍风险仍低于1%。

关键数值与推荐

  • 喉功能障碍定义为无局部复发情况下需气管造口或喉切除术。
  • 纳入标准为cTis-cT2期声门型喉癌接受根治性放疗;排除同步治疗、III-IV期、晚期严重毒性未知、姑息放疗、病例报告及非英文发表。

临床怎么用

  • 对于早期声门型喉癌,根治性放疗包括中度至(超)大分割方案时喉功能障碍风险低,可据此向患者说明保留喉功能的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotherapy is a common treatment for early-stage glottic cancer, with recent advances exploring smaller target volumes and (ultra-)hypofractionation. While (ultra-)hypofractionation offers potential advantages in treatment efficiency, concerns remain regarding increased late laryngeal toxicity. This systematic review and meta-analysis assessed the incidence of dysfunctional larynx -defined as the need for tracheostomy or laryngectomy without local recurrence- after radiotherapy for early-stage glottic cancer. This review was conducted following PRISMA guidelines. A comprehensive literature search was conducted up to September 2025. Studies were eligible if they included: (1) patients diagnosed with early-stage glottic carcinoma (cTis-cT2), (2) patients treated with definitive radiotherapy. Exclusion criteria were: (1) concurrent therapies (e.g. chemotherapy), (2) stage 3 or 4 laryngeal carcinoma, (3) unknown late severe toxicity (laryngectomy or tracheostomy), (4) palliative radiotherapy, (5) case reports and (6) not published in English. A total of 49 studies were included. The pooled analysis of all included studies, comprising 7033 patients, found a low overall incidence of 0.3 % for dysfunctional larynx. The risk of dysfunctional larynx remained low (<1%) for studies that used moderate to (ultra-)hypofractionation. These findings support the safety of contemporary radiotherapy approaches for preserving laryngeal function in this patient population.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Linden SML, Philippens MEP, Sher DJ, et al. Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: A systematic review and meta-analysis. Radiother Oncol. 2025. PMID: 41138858. doi:10.1016/j.radonc.2025.111226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。